Point-of-care testing hub

POCT market analysis and updates

Technology improvements, a growing need to expand access to testing for diverse test settings and users, are driving a decentralisation trend in in-vitro diagnostics (IVD) testing.

Clearstate offers point-of-care (POC) testing and device market data, forecasts, and trend predictions to give you the insight to adjust your business strategy to the increasing demand for affordable POC tests. Our POCT hub is regularly updated to share our findings on this fast-growing diagnostic alternative that is improving access to IVD testing.

Inquire now

What is point-of-care testing (POCT)?

Point-of-care testing (POCT), also known as near-patient testing (NPT), are tests performed outside the laboratory in different clinical settings – usually at the bedside or in wards utilising point-of-care testing devices. POCT can produce test results within minutes and are generally portable.

Explore the latest POCT market insights

From news to point-of-care diagnostics market analysis, our articles provide concise and up-to-date information about the developments driving testing closer to patients. Explore the latest in the point-of-care devices market, technology and applications as affordable solutions are developed and adopted in the market. Uncover the challenges and opportunities countries face to increase diagnostic coverage, disease monitoring and patient outcomes for the population through POCT.

Learn from leading experts and analysts, and see real-world examples on how IVD testing is decentralising.

APAC IVD companies to watch in the infectious diseases diagnostics market

Covid-19: point-of-care vs. lab-based testing

Covid-19 testing has emerged as a top priority for clinical laboratories and many IVD players. SARS-CoV-2 tests make up more than half of Asia-Pacific’s (APAC’s) total infectious disease diagnostics market.

Winning market share in the rise of connected blood glucose testing at Chinese hospitals

In China, the use of connected point-of-care (POC) blood glucose testing will play an increasingly important role in diabetes management at hospitals. China has the largest number of diabetes cases in the world. Besides patients hospitalised for diabetes complications, the country also has a large population of inpatients with high blood glucose levels which has been associated with increased hospitalisation expenses.

Point-of-Care Infectious Diseases Testing in Developing Countries infographic

Three test areas to watch in point-of-care infectious diseases testing in developing countries

In this infographic, EIU Healthcare picks out high-growth test areas in infectious diseases to watch based on data and forecasts from IVD Gateway, shedding light on where and how companies can help expand access to POC testing in developing countries.

Understand the POCT market

Discover more IVD insights or learn how our IVD Gateway solution can help prepare your business for the future impact of the decentralisation trend in testing unfolding across countries, and key customer segments across a wide range of applications.

report by clearstate

The Future of Point-of-Care (POC) Testing in Asia-Pacific (APAC)

Point-of-care (POC) diagnostics is expected to be one of the fastest-growing major in-vitro diagnostics (IVD) market segments in Asia-Pacific (APAC).

Learn more

report by clearstate

The future of point-of-care testing in Latin America

As Latin America (LATAM) experiences a shift towards decentralised IVD testing and greater constraints on fiscal budgets and healthcare systems, IVD companies will have to adapt their market strategy to meet the region’s increased demand for affordable point-of-care (POC) tests, particularly around infectious diseases.

Learn more

Clearstate newsletter

Sign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.